21st Century Cures Act Explained: Research Funding & Data Sharing

Hands holding a large red heart with silhouettes of a family, symbolizing care and support in human services case management.

In a contentious democracy such as ours it doesn’t seem to matter which party is in power, the incumbent bureaucracy is always in for constant criticism. That’s just the way energetic democracies work. However, this continuous debate often overlooks the good that each Congress might eke out.

The Evil that Men Do Lives after Them…The Good is Oft Interred with their Bones… ~ William Shakespeare

An example of some of the recent good Congress has done for public health is The Cures Act, or the 21st Century Cures Act, passed overwhelmingly in both the U.S. House of Representatives and Senate with strong bipartisan support and signed into law on December 13, 2016.

The Cures Act is one of the most sweeping and context-altering advances in public health ever enacted by Congress. The legislation provides the National Institute of Health with critical tools and resources to advance biomedical research, from basic research studies to advanced clinical trials of promising new therapies. The act also has a dramatic effect on patient care by improving medical information mobility between patients and their providers.

Yet, almost no one we unofficially poled, ever heard of The Cures Act.

21st Century Cures Act Funding for Biomedical Research

The Cures Act allocated funding to NIH over each of the 10 years following its passage in 2016 for a total of $4.8 billion. The Act required the NIH director to allocate funds to 4 areas of highly innovative scientific initiatives.

  1. Precision Medicine – The All of Us Research Program was built on a clear mission to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.
  2. Brain Research – Through the Advancing Innovative Neurotechnology Initiative, researchers seek to better understand how the brain encodes, stores, and retrieves information, which will transform the ability to diagnose and treat neurological/mental disorders.
  3. Cancer Moonshot – Launched in 2016 and reestablished in 2022, the Cancer Moonshot has the goal of making a decade’s worth of progress in cancer prevention, diagnosis, and treatment in five years.
  4. Regenerative Medicine – Innovation Project supports clinical research, in coordination with the FDA, using adult stem cells to further the ends of regenerative medicine, a field of medical science that aims to repair or replace damaged tissues and organs.

The Cares Act funding has two years left to run at the following funding levels:

Year        Precision Medicine    Brain Research Total

2025               $36 million                       $91 million $127 million

2026               $31 million                       $195 million $226 million

Early Results

  • Regenerative Medicine – In 2017, the first in vivo gene therapy and two CAR-T cell gene therapies for oncology were approved following the initial research.
  • Breakthrough (Brain) Devices Program – Early success created a brain implant that mimics light perception for patients with blindness.
  • Increased Drug Approvals – In 2018, the first full year after the Cures Act, the FDA approved a record 59 new drugs, compared to 22 in 2016.
  • The All of Us Research Program – The NIH is building a large, diverse national database of health information from over one million volunteers to accelerate precision medicine research.

Information Sharing and Management

In addition to funding critical leading-edge research, the Cures Act also addressed the access to medical records that HIPPA and other federal regulations were inadvertently blocking.

“The intent of the law is about accountability,” says Ellen Fink-Samnick, MSW, ACSW, LCSW, CCM, CCTP, CRP, DBH-C, principal of EFS Supervision Strategies. “The Cures Act is specific in its intent in that it outlaws any kind of information blocking, with blocking of patient data access being the primary area.”

  • Studies have shown that hundreds of thousands of patients experience preventable harm each year. Somewhere around 100,000 people die annually from medical errors.
  • There are two primary rules that have gone into effect regarding information blocking. The first is that patients must be granted access, as quickly as possible, to their patient information upon request, free of charge. Previously, HIPAA required providers to grant access within 30 days.
  • Under The Cures Act, providers are held more accountable because the information will be more readily shared.
  • Digging for detail and clarity alerts practitioners to the nuances of the law and allows them to identify what exactly applies to them. For example, under The Cures Act, clinical notes written by social workers in health care settings must not be blocked, nor can notes by social workers in mental health settings. Only notes that meet HIPAA’s definition of psychotherapy are excluded.

Credit Where Credit is Due

Healthy debate is a democracy’s life force. However, when it gets too intense, citizens tend to overlook the good and emphasize the bad. For more than 100 years, the U.S. Congress has been the backbone of social services and public health.

We must give credit where credit is due.


Further Reading & ResourcesFAMCare logo featuring a checkmark and the word "Resources," symbolizing nonprofit support and organizational tools.

Interested in learning more about how legislation like the Cures Act connects to innovation and accountability in human services? Here are a few resources to explore:

Share the Post: